Covington & Burling represented Thomson Reuters in a definitive agreement to sell its Healthcare business to an affiliate of Veritas Capital for $1.25 billion in cash.

The sale, expected to close in the next few months, is subject to regulatory approval and customary closing conditions, including the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act. 

Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. The Thomson Reuters healthcare business provides data, analytics and performance benchmarking solutions and services to hospitals, health systems, employers, health plans, government agencies and healthcare professionals. Veritas Capital is a leading private equity investment firm that invests in companies that provide critical products and services to government and commercial customers worldwide. Since its founding, Veritas Capital has been involved as the lead investor in transactions totaling more than $14 billion in value. 

The New York-based Covington corporate team was led by J. D. Weinberg. Also advising on the sale were Matthew Fox and Silas Lum (M&A), Lee Tiedrich and Jessica Milner (intellectual property), Nigel Howard, Vishnu Shankar and Larry Bartenev (technology transactions), David Rosinus and Robert Hemm (finance), Thomas Barnett, Miranda Cole and Henry Liu (antitrust), Michael Francese, Christen Sewell and Christopher Bracebridge (employee benefits), Robert Heller and Sarah Burnham (tax), Marialuisa Gallozzi (insurance), Robert Gage and Heather Haberl (real estate), Alan Pemberton and Jennifer Plitsch (government contracts), and Anna Kraus, Peter Flanagan, Michael Labson, Donald Ridings and Jennifer Saperstein (regulatory).